Promising New PD Fluid
In a Phase 2 study, PD-protec® from Zytoprotec in Vienna, Austria, reduced the risk of peritonitis and of membrane failure. The new fluid was well-tolerated, with no adverse events. Once on the market, this fluid could improve PD outcomes and allow more people to stay longer on the therapy.
Read the full article » | Posted 07/14/2017
- When Pigs Fly… Posted 09/15/2017
- Home Dialyzors United Helps Guide the Kidney Project Posted 09/15/2017
- DIY Dialysis? Posted 08/17/2017
- VasQ and A Posted 08/17/2017
- Transitioning Home Posted 07/14/2017